Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-009702
Filing Date
2024-12-11
Accepted
2024-12-11 16:59:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 6499
  Complete submission text file 0001950047-24-009702.txt   8062
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Subject) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41740 | Film No.: 241542229
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address
Dambkowski Carl (Reporting) CIK: 0001983476 (see all company filings)

Type: 144